George Wu is a strategic innovator specializing in biostatistics, drug development, and AI. From 2013 to 2015, they served as the lead statistician at Crescendo Bioscience, where they demonstrated the clinical utility of the VectraDA test for rheumatoid arthritis. Currently, as the Director of Biostatistics at Gilead Sciences, George develops innovative approaches to enhance drug development and has extensive trial experience in Virology and Oncology. They also earned a Ph.D. in Biostatistics from Johns Hopkins Bloomberg School of Public Health in 2013, after conducting significant research during their time as a graduate student researcher. George continues to pursue a Bachelor of Science in Bioengineering and Biomedical Engineering at UCSD.
This person is not in the org chart
This person is not in any teams
This person is not in any offices